{"id":47011,"date":"2022-08-07T10:01:38","date_gmt":"2022-08-07T08:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/"},"modified":"2022-08-07T10:01:38","modified_gmt":"2022-08-07T08:01:38","slug":"biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/","title":{"rendered":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022"},"content":{"rendered":"<div>\n<p>BRANFORD, Conn. &amp; NESS ZIONA, Israel&#8211;(BUSINESS WIRE)&#8211;BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 10, 2022, at 8:00 a.m. EDT, to report second quarter 2022 financial results and provide business updates. To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.biomx.com%2F&amp;esheet=52804437&amp;newsitemid=20220807005015&amp;lan=en-US&amp;anchor=www.biomx.com&amp;index=1&amp;md5=d9daec794a000868a1e363f6afb26e3e\" rel=\"nofollow noopener\" shape=\"rect\">www.biomx.com<\/a>.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/5\/final_biomx_logo-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg\"><\/a><\/p>\n<p>\n<b>About BiomX<\/b>\n<\/p>\n<p>\nBiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.\n<\/p>\n<p>\nAdditional information is available at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.biomx.com&amp;esheet=52804437&amp;newsitemid=20220807005015&amp;lan=en-US&amp;anchor=www.biomx.com&amp;index=2&amp;md5=6941d795fe2770ee1bdab8570afd4934\" rel=\"nofollow noopener\" shape=\"rect\">www.biomx.com<\/a>, the content of which does not form a part of this press release.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBiomX, Inc.<br \/>\n<br \/>Anat Primovich<br \/>\n<br \/>Corporate Project Manager<br \/>\n<br \/>+97250-6977228<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#111;&#x3a;&#x61;&#x6e;&#x61;&#x74;p&#64;&#98;&#105;&#111;&#109;&#x78;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#x6e;&#x61;&#x74;&#112;&#64;&#98;&#105;omx&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nInvestor Relations:<br \/>\n<br \/>LifeSci Advisors, LLC<br \/>\n<br \/>John Mullaly<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#x3a;&#106;m&#x75;&#x6c;&#x6c;&#97;l&#x79;&#x40;&#x6c;&#105;f&#x65;&#x73;&#x63;&#105;a&#x64;&#x76;&#x69;&#115;o&#x72;&#x73;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">jmu&#108;&#108;&#97;&#108;&#x79;&#x40;&#x6c;&#x69;&#x66;&#x65;&#x73;cia&#100;&#118;&#105;&#115;&#111;&#x72;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRANFORD, Conn. &amp; NESS ZIONA, Israel&#8211;(BUSINESS WIRE)&#8211;BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 10, 2022, at 8:00 a.m. EDT, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47011","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BRANFORD, Conn. &amp; NESS ZIONA, Israel&#8211;(BUSINESS WIRE)&#8211;BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 10, 2022, at 8:00 a.m. EDT, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-07T08:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022\",\"datePublished\":\"2022-08-07T08:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/\"},\"wordCount\":201,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005015\\\/en\\\/1537104\\\/21\\\/final_biomx_logo-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/\",\"name\":\"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005015\\\/en\\\/1537104\\\/21\\\/final_biomx_logo-01.jpg\",\"datePublished\":\"2022-08-07T08:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005015\\\/en\\\/1537104\\\/21\\\/final_biomx_logo-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005015\\\/en\\\/1537104\\\/21\\\/final_biomx_logo-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/","og_locale":"en_US","og_type":"article","og_title":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend","og_description":"BRANFORD, Conn. &amp; NESS ZIONA, Israel&#8211;(BUSINESS WIRE)&#8211;BiomX Inc. (NYSE American: PHGE) (\u201cBiomX\u201d or the \u201cCompany\u201d), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, August 10, 2022, at 8:00 a.m. EDT, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-07T08:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022","datePublished":"2022-08-07T08:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/"},"wordCount":201,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/","url":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/","name":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg","datePublished":"2022-08-07T08:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220807005015\/en\/1537104\/21\/final_biomx_logo-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biomx-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-august-10-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47011"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47011\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}